In January 2025, as part of its decision-making process, the EC asked the CHMP to consider information on the safety of lecanemab that became available after the adoption of the CHMP opinion in ...
STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP ...
Viehbacher, "Biogen") announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has reaffirmed its positive opinion by consensus for the anti ...
The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...
You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...
Krystal Biotech's VYJUVEK, a first-mover gene therapy for DEB, has received a positive CHMP recommendation. Read why KRYS ...
Vietnam Investment Review on MSN2d
Neurim Pharmaceuticals Gains EU Approval for Pediatric Melatonin to Treat Insomnia in Children with ADHDNeurim Pharmaceuticals ("Neurim") announces that the European Commission has approved the extension of the indication to include the treatment of insomnia in children with attention deficit ...
Following a flurry of activity at this month’s meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), drugmakers are celebrating a bevy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback